Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3359)
All Articles published online
|
Feb 14, 2005 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cao HJ, Fang Y, Zhang X, Chen WJ, Zhou WP, Wang H, Wang LB, Wu JM. Tumor metastasis and the reciprocal regulation of heparanase gene expression by nuclear factor kappa B in human gastric carcinoma tissue. World J Gastroenterol 2005; 11(6): 903-907 [PMID: 15682491 DOI: 10.3748/wjg.v11.i6.903] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i6/903.htm |
| Number | Citing Articles |
| 1 |
Y Yang, C Gorzelanny, A T Bauer, N Halter, D Komljenovic, T Bäuerle, L Borsig, M Roblek, S W Schneider. Nuclear heparanase-1 activity suppresses melanoma progression via its DNA-binding affinity. Oncogene 2015; 34(47): 5832 doi: 10.1038/onc.2015.40
|
| 2 |
Melissa L.T. Teoh, Matthew P. Fitzgerald, Larry W. Oberley, Frederick E. Domann. Overexpression of Extracellular Superoxide Dismutase Attenuates Heparanase Expression and Inhibits Breast Carcinoma Cell Growth and Invasion. Cancer Research 2009; 69(15): 6355 doi: 10.1158/0008-5472.CAN-09-1195
|
| 3 |
Fang Zhou, Hongjun Wei, Aiping Ding, Wensheng Qiu, Lingxin Feng, Quan Zhou, Jun Liang, Lu Yue. Different Cellular Localization of NF‐κB p65 Expression as an Indicator of Different Prognoses of Stage I–III Gastric Cancer Patients. Clinical and Translational Science 2013; 6(5): 381 doi: 10.1111/cts.12065
|
| 4 |
Xiaodong Xu, Yingjie Xia, Jie Ma, Weijun Li, Nan Niu, Xiao Li, Houquan Tao, Ji Xu, Xujun He. Upregulation of miRNA‑301a‑3p promotes tumor progression in gastric cancer by suppressing NKRF and activating NF‑κB signaling. International Journal of Oncology 2020; 57(2): 522 doi: 10.3892/ijo.2020.5072
|
| 5 |
Chia Huey Ooi, Tatiana Ivanova, Jeanie Wu, Minghui Lee, Iain Beehuat Tan, Jiong Tao, Lindsay Ward, Jun Hao Koo, Veena Gopalakrishnan, Yansong Zhu, Lai Ling Cheng, Julian Lee, Sun Young Rha, Hyun Cheol Chung, Kumaresan Ganesan, Jimmy So, Khee Chee Soo, Dennis Lim, Weng Hoong Chan, Wai Keong Wong, David Bowtell, Khay Guan Yeoh, Heike Grabsch, Alex Boussioutas, Patrick Tan, Jason G. Mezey. Oncogenic Pathway Combinations Predict Clinical Prognosis in Gastric Cancer. PLoS Genetics 2009; 5(10): e1000676 doi: 10.1371/journal.pgen.1000676
|
| 6 |
Hao-Hueng Chang, Mark Yen-Ping Kuo, Shih-Jung Cheng, Chun-Pin Chiang. Expression of BCL10 is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan. Oral Oncology 2009; 45(7): 589 doi: 10.1016/j.oraloncology.2008.08.003
|
| 7 |
W Weichert, M Boehm, V Gekeler, M Bahra, J Langrehr, P Neuhaus, C Denkert, G Imre, C Weller, H-P Hofmann, S Niesporek, J Jacob, M Dietel, C Scheidereit, G Kristiansen. High expression of RelA/p65 is associated with activation of nuclear factor-κB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis. British Journal of Cancer 2007; 97(4): 523 doi: 10.1038/sj.bjc.6603878
|
| 8 |
Jing Shi, Yi-Ping Qu, Peng Hou. Pathogenetic mechanisms in gastric cancer. World Journal of Gastroenterology 2014; 20(38): 13804-13819 doi: 10.3748/wjg.v20.i38.13804
|
| 9 |
Daniel Rojo, Alejandro Madrid, Sebastián San Martín, Mario Párraga, Maria Aparecida Silva Pinhal, Joan Villena, Manuel Valenzuela-Valderrama. Resveratrol Decreases the Invasion Potential of Gastric Cancer Cells. Molecules 2022; 27(10): 3047 doi: 10.3390/molecules27103047
|
| 10 |
Domenica Rea, Giovanni Coppola, Giuseppe Palma, Antonio Barbieri, Antonio Luciano, Paola Del Prete, Sabrina Rossetti, Massimiliano Berretta, Gaetano Facchini, Sisto Perdonà, Maria Caterina Turco, Claudio Arra. Microbiota effects on cancer: from risks to therapies. Oncotarget 2018; 9(25): 17915 doi: 10.18632/oncotarget.24681
|
| 11 |
Ching-Chuan Su, Chau-Jong Wang, Kai-Hsun Huang, Yi-Ju Lee, Wei-Ming Chan, Yun-Ching Chang. Anthocyanins from Hibiscus sabdariffa calyx attenuate in vitro and in vivo melanoma cancer metastasis. Journal of Functional Foods 2018; 48: 614 doi: 10.1016/j.jff.2018.07.032
|
| 12 |
Xiaohong Wu, Yong Zhang, Junping Guo, Xun Yan, Li Shen, Jianping Zhou, Jun Zhao, Min Zhuang, Zhihong Cao. MAC30 Knockdown Inhibits Proliferation and Enhance Apoptosis of Gastric Cancer by Suppressing Wnt/β-Cateninsignaling Pathway. Gastroenterology Research and Practice 2020; 2020: 1 doi: 10.1155/2020/6358685
|
| 13 |
Bo Tang, Shiming Yang. Heparanase. Advances in Experimental Medicine and Biology 2020; 1221: 351 doi: 10.1007/978-3-030-34521-1_13
|
| 14 |
Satvik R. Hadigal, Alex M. Agelidis, Ghadah A. Karasneh, Thessicar E. Antoine, Abraam M. Yakoub, Vishnu C. Ramani, Ali R. Djalilian, Ralph D. Sanderson, Deepak Shukla. Heparanase is a host enzyme required for herpes simplex virus-1 release from cells. Nature Communications 2015; 6(1) doi: 10.1038/ncomms7985
|
| 15 |
Christophe Gallard, Nadjet Lebsir, Hira Khursheed, Emma Reungoat, Marie-Laure Plissonnier, Jennifer Bré, Maud Michelet, Yasmina Chouik, Fabien Zoulim, Eve-Isabelle Pécheur, Birke Bartosch, Boyan Grigorov. Heparanase-1 is upregulated by hepatitis C virus and favors its replication. Journal of Hepatology 2022; 77(1): 29 doi: 10.1016/j.jhep.2022.01.008
|
| 16 |
Liping Liu, Yongxun Zhao, Guangrui Fan, Tiankui Shuai, Bin Li, Yumin Li. Helicobacter�pylori infection enhances heparanase leading to cell proliferation via mitogen‑activated protein kinase signalling in human gastric cancer cells. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.9558
|
| 17 |
Veronique Vreys, Guido David. Mammalian heparanase: what is the message?. Journal of Cellular and Molecular Medicine 2007; 11(3): 427 doi: 10.1111/j.1582-4934.2007.00039.x
|
| 18 |
Md. Rezaul Islam, Abdur Rauf, Shopnil Akash, Ajoy Kumer, Md Sadique Hussain, Smrity Akter, Jeetendra Kumar Gupta, L.H. Thameemul Ansari, Mir Md. Mahfoj Islam Raj, Talha Bin Emran, Abdullah S.M. Aljohani, Waleed Al Abdulmonem, Rekha Thiruvengadam, Muthu Thiruvengadam. Recent perspective on the potential role of phytocompounds in the prevention of gastric cancer. Process Biochemistry 2023; 135: 83 doi: 10.1016/j.procbio.2023.11.006
|
| 19 |
Maria Francesca Secchi, Valentina Masola, Gianluigi Zaza, Antonio Lupo, Giovanni Gambaro, Maurizio Onisto. Recent data concerning heparanase: focus on fibrosis, inflammation and cancer. Biomolecular Concepts 2015; 6(5-6): 415 doi: 10.1515/bmc-2015-0021
|
| 20 |
Alex Agelidis, Deepak Shukla. Heparanase. Advances in Experimental Medicine and Biology 2020; 1221: 759 doi: 10.1007/978-3-030-34521-1_32
|
| 21 |
R. C. Turkington, C. Purcell, C. R. James, J. Millar, E. Napier, D. Law, R. Gallagher, M. Morris, R. H. Wilson, M. M. Eatock. A phase I trial of bortezomib in combination with epirubicin, carboplatin and capecitabine (ECarboX) in advanced oesophagogastric adenocarcinoma. Investigational New Drugs 2014; 32(2): 250 doi: 10.1007/s10637-013-9970-7
|
| 22 |
Vishnu C. Ramani, Israel Vlodavsky, Mary Ng, Yi Zhang, Paola Barbieri, Alessandro Noseda, Ralph D. Sanderson. Chemotherapy induces expression and release of heparanase leading to changes associated with an aggressive tumor phenotype. Matrix Biology 2016; 55: 22 doi: 10.1016/j.matbio.2016.03.006
|
| 23 |
Israel Vlodavsky, Preeti Singh, Ilanit Boyango, Lilach Gutter-Kapon, Michael Elkin, Ralph D. Sanderson, Neta Ilan. Heparanase: From basic research to therapeutic applications in cancer and inflammation. Drug Resistance Updates 2016; 29: 54 doi: 10.1016/j.drup.2016.10.001
|